FDA Approves Exelon Patch for Severe Alzheimer'sFDA Approves Exelon Patch for Severe Alzheimer's

The rivastigmine transdermal system, already approved for mild to moderate AD, is now approved across all stages of the disease. FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news